USPTO trademark

AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE

AllowedUSPTOWord and designClass 5

"AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE" is a word and design mark owned by Seqirus Inc., filed at the USPTO on August 26, 2025. It has been allowed and covers class 5 (Pharmaceuticals).

View Seqirus Inc. portfolioGet this data via the API
Official USPTO record
AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE trademark as filed
As filed with the USPTO
Status
Allowed
Since May 21, 2026
Filed
August 26, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99358160
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word and design
1 class
Ownership

Who owns AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Seqirus Inc.

Holly Springs, United States

231 trademarks in the portfolioView company

Representative

Nancy Sabarra

Fross Zelnick Lehrman & Zissu, P.C.

Goods and services

What the mark covers

The products and services AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE is filed for, grouped by Nice class.

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of approval of extension request e-mailed
  2. Sou extension 1 granted
  3. Sou extension 1 filed
  4. Sou teas extension received
  5. Noa e-mailed - sou required from applicant
  6. Official gazette publication confirmation e-mailed
  7. Published for opposition
  8. Notification of notice of publication e-mailed
  9. Approved for pub - principal register
  10. Assigned to examiner

7 earlier steps on the official record.

FAQ

About AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE

Who owns the trademark "AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE"?

The USPTO trademark "AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE" (application 99358160) is owned by Seqirus Inc.

What is the status of "AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b19-d43d-745a-88e8-1bf6f2f096c1
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b19-d43d-745a-88e8-1bf6f2f096c1",
  "object": "trademark",
  "mark_text": "AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99358160",
  "filing_date": "2025-08-26",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Seqirus Inc.",
      "entity_id": "ent_019eb7d7-073e-746b-967e-2a965cfa764c"
    }
  ]
}